Subclinical thyrotoxicosis.
Yeo
P P
PP
Department of Medicine, University of California-San Francisco, USA.
Loh
K C
KC
D001281:Atrial Fibrillation / Q000503:physiopathology; D015415:Biomarkers / Q000032:analysis; D015519:Bone Density; D001862:Bone Resorption / Q000503:physiopathology; D001842:Bone and Bones / Q000378:metabolism; D003937:Diagnosis, Differential; D006321:Heart / Q000502:physiology; D006331:Heart Diseases / Q000503:physiopathology; D006801:Humans; D008903:Minerals / Q000378:metabolism; D010902:Pituitary Gland / Q000502:physiology; D015995:Prevalence; D013961:Thyroid Gland / Q000502:physiology; D013971:Thyrotoxicosis / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology / Q000503:physiopathology*; D013972:Thyrotropin / Q000032:analysis / Q000097:blood / Q000378:metabolism; D013974:Thyroxine / Q000037:antagonists & inhibitors / Q000097:blood / Q000378:metabolism; D014284:Triiodothyronine / Q000097:blood / Q000378:metabolism
D015415:Biomarkers; D008903:Minerals; D014284:Triiodothyronine; D013972:Thyrotropin; D013974:Thyroxine